Knight Therapeutics Inc. (TSX: GUD)

Knight Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	73.76	58.76	71.68	85.96	229.59	169.27
Short-Term Investments	98.56	95.66	85.83	63.54	147.32	238.49
Trading Asset Securities	-	15.45	28.11	10.65	29.15	6.54
Cash & Short-Term Investments	172.32	169.87	185.61	160.16	406.05	414.3
Cash Growth	7.75%	-8.48%	15.89%	-60.56%	-1.99%	-40.49%
Accounts Receivable	91.25	88.72	94.89	55.39	62.52	85.85
Other Receivables	11.75	9.51	13.68	12.03	19.53	25.89
Receivables	103	98.23	114	69.96	87.15	125.17
Inventory	114.96	91.83	92.49	72.4	56.51	70.87
Prepaid Expenses	7.29	4.88	3.34	2.17	2.21	3.31
Restricted Cash	-	-	-	-	-	5
Other Current Assets	-	0.3	0.18	0.29	0.18	2.88
Total Current Assets	397.57	365.12	395.62	304.97	552.1	621.52
Property, Plant & Equipment	21.64	17.86	22.63	29.94	26.16	29.05
Long-Term Investments	105.64	116.36	152.33	174.23	169.79	241.13
Goodwill	84.78	79.84	82.27	75.4	77.73	88.26
Other Intangible Assets	279.68	289.96	338.78	350.3	156.55	173.37
Long-Term Accounts Receivable	-	-	-	-	-	4.72
Long-Term Deferred Tax Assets	20.9	19.39	9.31	2.05	2.43	3.99
Other Long-Term Assets	52.08	53.3	50.13	51.28	51.18	126.13
Total Assets	962.29	945.49	1,055	991.89	1,040	1,305
Accounts Payable	86.62	85.37	106.06	65.31	44.51	72.83
Accrued Expenses	-	-	-	-	-	21.58
Short-Term Debt	-	0.61	1.61	9.19	10.11	-
Current Portion of Long-Term Debt	18.69	17.24	16.06	17.48	41.66	50.56
Current Portion of Leases	3.02	1.73	2.58	1.61	1.88	1.79
Current Income Taxes Payable	2.49	1.18	2.27	7.07	13.56	15.45
Other Current Liabilities	7.33	7.9	12.73	4.64	2.34	188.61
Total Current Liabilities	118.15	114.03	141.32	105.3	114.06	350.8
Long-Term Debt	32.96	44.02	52.4	9.27	-	5.02
Long-Term Leases	3.55	5.5	5.05	3.42	2.54	4.81
Long-Term Deferred Tax Liabilities	4.26	2.82	4.37	12.37	21.62	27.86
Other Long-Term Liabilities	29.46	32.26	25.85	19.52	15.22	1.7
Total Liabilities	188.39	198.62	228.98	149.87	153.44	390.2
Common Stock	539.32	540.05	599.06	628.85	694.35	723.83
Additional Paid-In Capital	26.22	25.99	23.66	21.78	18.73	16.46
Retained Earnings	144.18	150.89	161.76	191.65	174.55	52.25
Comprehensive Income & Other	64.19	29.95	41.38	-0.26	-1.39	18.19
Total Common Equity	773.91	746.87	825.86	842.02	886.24	810.73
Minority Interest	-	-	-	-	-	104.38
Shareholders' Equity	773.91	746.87	825.86	842.02	886.24	915.11
Total Liabilities & Equity	962.29	945.49	1,055	991.89	1,040	1,305
Total Debt	58.22	69.09	77.7	40.96	56.19	62.18
Net Cash (Debt)	117.88	108.18	123.08	119.2	365.18	478.99
Net Cash Growth	37.91%	-12.10%	3.26%	-67.36%	-23.76%	-39.63%
Net Cash Per Share	1.16	1.01	1.07	0.96	2.77	3.42
Filing Date Shares Outstanding	100.8	101.17	110.13	117.03	128.76	135.38
Total Common Shares Outstanding	100.98	101.17	112.21	117.78	130.04	135.64
Working Capital	279.41	251.09	254.3	199.67	438.04	270.72
Book Value Per Share	7.66	7.38	7.36	7.15	6.82	5.98
Tangible Book Value	409.45	377.07	404.8	416.32	651.97	549.1
Tangible Book Value Per Share	4.05	3.73	3.61	3.53	5.01	4.05
Land	-	0.93	1.55	1.09	0.89	0.96
Buildings	-	9.84	14.56	7.69	6.3	6.38
Machinery	-	21.91	33.13	25.94	18.16	15.01

Source: S&P Capital IQ. Standard template. Financial Sources.